Curaderm Global’s contribution towards over 2000+ Independent Published Scientific articles of our GLYCOALKALOID INVENTION from the period 1987 to 2024

(Click on the Doi link then download the PDF version)

2024
T.R. Chase, K.E. Cham and B.E. Cham.
Unique Clinical Features of Curaderm when Treating Skin Cancers. Journal of Cancer Therapy. 15, 13-27.
Doi: 10.4236/jct.2024.151002

T.R. Chase, K.E. Cham and Cham, B.E.  (2024).  The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer Treatment.  International Journal of Clinical Medicine.  15, 68-87
Doi: 10.4236/ijcm.2024.152005

2023
Cham, B.E.
Holistic Approach in the Treatment of Actinic Keratosis: Benefits and Disadvantages of 5-Fluorouracil, Imiquimod, Diclofenac and Curaderm. International Journal of Clinical Medicine. 14,319-331.
Doi: 10.4236/ijcm.2023.147027

2022
Cham, B.E.
The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma. Clinical Medicine Review and Case Reports. 9, 399.
Doi: 10.23937/2378-3656/1410399

2021
The Evolution of Curaderm which led to the Revolution of Skin Cancer treatment. eBook. Cham, B.E. Amazon US. https://www.amazon.com/EVOLUTION-CURADERM-EGGPLANT-REVOLUTION-TREATMENT-ebook/dp/B09MVP5M3L/ref=sr_1_1?keywords=the+evolution+of+curaderm&qid=1639040738&sr=8-1

2020
Cham, B.E.
Critical study on topical CuradermBEC therapy for periocular nonmelanoma skin cancers: A review of clinical outcomes. Current topics in Med. Medical Res. ISBN: 978-93-90149-59-9. Vol 1, 142-151.
DOI:10.4236/ijcm.2013.45041

Cham, B.E.
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute survival. Journal of Cancer Therapy. 11(8), 470-482.
Doi: 10.4236/jct.2020.118040

Chase, T., Cham, K.E., Cham, B.E.
Evaluation of Dermal Irritation and Skin Sensitization by Curaderm. International Journal of Clinical Medicine. 11(9), 548-558.
Doi: 10.4236/ijcm.2020.119047

Chase, T., Cham, K.E. Cham, B.E.
Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma. International Journal of Clinical Medicine. 11(10), 579-604.
Doi: 10.4236/ijcm.2020.1110050

Cham, B.E.
First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm. Journal of Cancer Therapy. 11(10), 617-630.
Doi: 10.4236/jct.2020.1110052

2019
Cham, B.E.
Solasodine glycosides from the eggplant in a topical cream Psorend^BEC are effective against Psoriasis. International Journal Clinical Medicine. 10(3), 174-182.
Doi: 10.4236/ijcm.2019.103017

2017
Cham, B.E.
Solasodine, solamargine and mixtures of solasodine rhamnosides: Pathway to expansive clinical anticancer therapies. International Journal of Clinical Medicine. 8(12), 692-713.
Doi: 10.4236/ijcm.2017.812064

2016
Batsev, A.F., Dobrokhotova, V.Z. and Cham, B.E.
Topical cream Curaderm^BEC5 Treats a Recalcitrant Basal Cell Carcinoma. Clinical Medicine Reviews and Case Reports. 3:098, 3(3) 1-3.
Doi: 10.23937/2378-3656/1410098

Tambuscio, A., Siliprandi, L., Dario, M., Cham, A., Cham, B. E. and Bordignon, M. Treatment of cutaneous carcinomas with a topical cream containing solasodine rhamnosides: Focus on efficacy, compliance and cosmetic outcomes. European Academy of Dermatology and Venereology Congress. Athens, Greece.

Dobrokhotova, F.Z., Betsev, A.F. and Belysheva, T.S.
The Use of Kuraderm Drug in the Treatment of Basal Cell Carcinoma of the Head and Neck. Head and Neck Tumors. 6, 22-26.
Doi: 10.17650/2222-1468-2016-6-3-22-26

Cham, B.E.
Plant extracted solasodine rhamnosides, a new era for cancer therapy? International Conference on Cancer Research & Targeted Therapy. October 21-23. Baltimore, MD, USA (CRT-2016).

2015
Cham, A., Cham, K., Chase T. and Cham, B.E.
A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: relevance to BEC and solamargine, a topical clinical formulation Curaderm^BEC5. Journal Cancer Treatment and Research. 3(2), 22-27.
Doi: 10.11648/j.jctr.20150302.12

Cham, A and Cham, B.E.
Treatment of skin cancer with a selective apoptotic–inducing Curaderm^BEC5 topical cream containing solasodine rhamnosides. International Journal Clinical Medicine. 6(5), 326-333.
Doi: 10.4236/ijcm.2015.65042

Cham, B.E.
Curaderm^BEC5, Natural Non-Invasive Medication * For Skin Cancer. *Biopsy and 5-year cancer-free criteria. 2nd Edition Curaderm Global Ltd. ISBN-13: 978-0-646-92463-2.

Cham, B.E., Cham, K., Cham, A., Chase, T. and Zhou, V.
Treatment of non melanoma skin cancers: An intra-Comparison study of Curaderm^BEC5 and various established modalities. Journal Cancer Therapy. 6(12), 1045-1053.
Doi: 10.4236/jct.2015.612114

2014
Cham, B.E. A Review of Solasodine Rhamnosides Therapy for in-situ squamous cell carcinoma on the Penis. Journal of Advances in Medicine and Medical Research. 4(2), 621-631.
Doi: 10.9734/BJMMR/2014/4677

Curaderm^BEC5, Natural Non-Invasive Cure * For Skin Cancer. *Biopsy and 5-year cancer-free criteria. 1^st Edition Curaderm Global Ltd. Cham, B.E. ISBN-13: 978-0-646-92463-2.

2013
Cham, B.E.
Inspired by Nature, Proven by Science. The new generation cancer treatment that causes cancer cells to commit suicide. ISBN=978-1-62951-158-0.

Cham, B.E.
Topical Curaderm ^BEC5 Therapy for Periocular Nonmelanoma Skin Cancer: A Review of Clinical Outcomes. International Journal of Clinical Medicine. 4(5), 233-238.
Doi: 10.4236/ijcm.2013.45041

Cham, B.E.
Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm ^BEC5. Journal of Cancer Therapy. 4(2), 588-596.
Doi: 10.4236/jct.2013.42076

Cham, B.E.
Drug Therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents. Modern Chemotherapy. 2(2), 33-49.
Doi: 10.4236/mc.2013.22005

2012
Cham, B.E. and Chase T.R.
Solasodine Rhamnosyl Glycosides Cause Apoptosis in Cancer Cells, Do They Also Prime the Immune System Resulting in Long Term Protection? Planta Medica. 78(4), 349-353.
Doi: 10.1055/s-0031-1298149

Cham, B.E.
Intralesion and Curaderm BEC topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared. International Journal of Clinical Medicine. 3(2), 115-124.
Doi: 10.4236/ijcm.2012.32024

2011
Cham, B.E.
Topical Solasodine Rhamnosyl Glycosides Derived From the Eggplant Treats Large Skin Cancers: Two Case Reports. International Journal of Clinical Medicine. 2(4), 473-477.
Doi: 10.4236/ijcm.2011.24080

Chase T. R.
Curaderm ^BEC5 For Skin Cancers, Is It? An Overview. Journal Cancer Therapy. 2, 728-745.
Doi: 10.4236/jct.2011.25099

2009
Cham, B.E.
When does alternative become orthodox? Skin cancer treatment with solasodine rhamnosyl glycosides in its transitional stage, a case study. Evidence-Based Complementary and Alternative Medicine. 6(3), 415-420.

2008
Cham, B.E.
Cancer intralesion chemotherapy with solasodine rhamnosyl glycosides. Research Journal of Biological Sciences. 3(9), 1008-1017.

2007
Cham, B.E.
The Eggplant Cancer Cure: A Treatment for Skin Cancers and New Hope for Other Cancers from Nature’s Pharmacy. Smart Publications.

Cham, B.E.
Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences. 2(4), 503-514.

Cham, B.E.
Solasodine rhamnosyl glycosides in a cream formulation is effective for treating large and troublesome skin cancers. Research Journal of Biological Sciences. 2(7), 749-761.

2006
Cham, B.E.
The discovery of a natural cream that eats cancer. International Antiaging. 37-39.

2005
Cham, B.E.
BEC5-Curaderm, the treatment of choice for non-melanoma skin cancers. International Antiaging. 7-10.

1994
Cham, B.E.
Solasodine glycosides as anti-cancer agents: Pre-clinical and clinical studies. Asia Pacific Journal of Pharmacology. 9, 113-118.

1992
Cham, B.E., Daunter, B. and Evans, R.
Topical treatment of malignant and premalignant skin cancers by very low concentrations of A standard mixture of solasodine glycosides. Clinical Digest Series. Dermatology. 1992.

1991
Cham, B.E., Daunter, B. and Evans, R.
Topical treatment of malignant and premalignant skin cancers by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Letters 59, 183-192.
Doi: 10.1016/0304-3835(91)90140-D

1990
Cham, B.E., Daunter, B. and Evans, R.
Topical treatment for pre-malignant and malignant skin cancers with Curaderm. Drugs of Today 26, 55-58.

Cham, B.E. and Daunter, B.
Curaderm. Medical Journal of Australia. 152, 329-330.

Daunter, B. and Cham, B.E.
Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells. Cancer Letters 55, 209-220.
Doi: 10.1016/0304-3835(90)90121-D

Cham, B.E. and Daunter, B.
Solasodine glycosides. Selective cytoxicity for cancer cells and inhibition of cytotoxicity by rhamnose in mice with sarcoma 180. Cancer Letters. 55, 221-225.
DOI: 10.1016/0304-3835(90)90122-e

1989
Cham, B.E.
Curaderm (antineoplastic). Launched in Australia. Drug News and Perspectives 2, 112.

Cham, B.E.
Plants yield skin cancer cure. Australian Technology Review. 2, 53.

Evans, R., Cham, B.E. and Daunter, B.
Letter to the Editor. Medical Journal of Australia. 150, 350-351.

Evans, R., Cham, B.E. and Daunter, B.
Letters to the Editor. Your Pharmacy, January 1.

1988
Cham, B.E.
Monograph on the compound BEC. Drugs of the Future. 13, 714-716.

1987
Cham, B.E. and Wilson, L.
HPLC of glycoalkaloids from Solanum sodomaeum L. Planta Medica. 53, 59-62.
Doi: 10.1055/s-2006-962621

Cham, B.E., Gilliver, M. and Wilson, L.
Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum L. Planta Medica. 53, 63-64.
DOI: 10.1055/s-2006-962612

Cham, B.E. and Meares, H.M.
Glycoalkaloids from Solanum sodomaeum L. are effective in the treatment of skin cancers in man. Cancer Letters 36, 111-118.
Doi: 10.1016/0304-3835(87)90081-4